Kangtai Medical announced that the company recently received the “Medical Device Change Registration Document” issued by the Hebei Drug Administration, involving multi-parameter vital signs monitors. The changes include specifications, models, scope of application, structure and composition, and product technical requirements. The approval date is September 21, 2026. This change is in line with market demand, helps enhance the company's market competitiveness and broaden its business coverage. It has a positive effect on the company's long-term development, and its impact on future business performance cannot yet be predicted.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.